These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1648111)
21. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Lee JM; Kim CS; Youk JH; Lee MS Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629 [TBL] [Abstract][Full Text] [Related]
22. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media]. Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451 [TBL] [Abstract][Full Text] [Related]
23. MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool. Helmberger TK; Laubenberger J; Rummeny E; Jung G; Sievers K; Döhring W; Meurer K; Reiser MF Eur Radiol; 2002 Jan; 12(1):62-70. PubMed ID: 11868075 [TBL] [Abstract][Full Text] [Related]
24. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients. Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854 [TBL] [Abstract][Full Text] [Related]
25. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227. Harisinghani MG; Saini S; Weissleder R; Halpern EF; Schima W; Rubin DL; Stillman AE; Sica GT; Small WC; Hahn PF Radiology; 1997 Mar; 202(3):687-91. PubMed ID: 9051017 [TBL] [Abstract][Full Text] [Related]
26. T2 relaxation times of hypervascular and non-hypervascular liver lesions: do hypervascular lesions mimic haemangiomas on heavily T2-weighted MR images? McNicholas MM; Saini S; Echeverri J; Foley M; Kaufman J; McFarland E; Hahn PF Clin Radiol; 1996 Jun; 51(6):401-5. PubMed ID: 8654003 [TBL] [Abstract][Full Text] [Related]
27. Focal liver lesions: characterization with quantitative analysis of T2 relaxation time in TSE sequence with double echo time. Cittadini G; Santacroce E; Giasotto V; Rescinito G Radiol Med; 2004 Mar; 107(3):166-73. PubMed ID: 15031682 [TBL] [Abstract][Full Text] [Related]
28. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222 [TBL] [Abstract][Full Text] [Related]
29. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287 [TBL] [Abstract][Full Text] [Related]
30. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI]. Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107 [TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging (MRI) in 100 cases of mass lesions in the liver. Meng T; Su XZ Chin Med J (Engl); 1990 Aug; 103(8):673-9. PubMed ID: 2173656 [TBL] [Abstract][Full Text] [Related]
32. Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions. Fu GL; Du Y; Zee CS; Yang HF; Li Y; Duan RG; Zeng NL; Xiao DM J Comput Assist Tomogr; 2012; 36(1):14-9. PubMed ID: 22261765 [TBL] [Abstract][Full Text] [Related]
33. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging. Scharitzer M; Schima W; Schober E; Reimer P; Helmberger TK; Holzknecht N; Stadler A; Ba-Ssalamah A; Weber M; Wrba F J Comput Assist Tomogr; 2005; 29(2):181-90. PubMed ID: 15772534 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of diffusion weighted imaging of magnetic resonance imaging in small focal hepatic lesions: a quantitative study in 56 cases. Quan XY; Sun XJ; Yu ZJ; Tang M Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):406-9. PubMed ID: 16109526 [TBL] [Abstract][Full Text] [Related]
36. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging. Saini S; Sharma R; Baron RL; Turner DA; Ros PR; Hahn PF; Small WC; Delange EE; Stillman AE; Edelman RR; Runge VM; Outwater EK Clin Radiol; 2000 Sep; 55(9):690-5. PubMed ID: 10988047 [TBL] [Abstract][Full Text] [Related]
37. MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors. Mattison GR; Glazer GM; Quint LE; Francis IR; Bree RL; Ensminger WD AJR Am J Roentgenol; 1987 Apr; 148(4):711-5. PubMed ID: 3030082 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver. Tokgoz O; Unlu E; Unal I; Serifoglu I; Oz I; Aktas E; Caglar E Afr Health Sci; 2016 Mar; 16(1):227-33. PubMed ID: 27358636 [TBL] [Abstract][Full Text] [Related]
39. Routine MR imaging protocol with breath-hold fast scans: diagnostic efficacy for focal liver lesions. Tanimoto A; Yuasa Y; Jinzaki M; Nakatsuka S; Takeda T; Kurata T; Shinmoto H; Kuribayashi S Radiat Med; 2002; 20(4):169-79. PubMed ID: 12296432 [TBL] [Abstract][Full Text] [Related]
40. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. Chiu FY; Jao JC; Chen CY; Liu GC; Jaw TS; Chiou YY; Hsu FO; Hsu JS J Comput Assist Tomogr; 2005; 29(2):176-80. PubMed ID: 15772533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]